Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Clin Oncol. Apr 24, 2023; 14(4): 179-189
Published online Apr 24, 2023. doi: 10.5306/wjco.v14.i4.179
Table 4 Joint test analysis of the predictors of extramedullary multiple myeloma and overall mortality among United States extramedullary multiple myeloma patients, 2000-2017
VariablesMM mortality
Overall mortality
DF
χ2
P value
χ2
P value
Race/ethnicity35.74360.12483.24030.3560
Age at diagnosis321.2193< 0.000149.2869< 0.0001
Gender10.50440.47760.51680.4722
Extramedullary Site1116.60700.120015.65780.1543
Living area42.10230.71690.81750.9361
Income57.35390.19567.41570.1915
Marital status310.81830.012811.79670.0081
chemotherapy12.31040.12851.45360.2280
Year of diagnosis1725.31420.087916.18480.5108
Interaction between age and gender32.12850.54621.02960.7941

  • Citation: Bangolo AI, Fwelo P, Trivedi C, Sagireddy S, Aljanaahi H, Auda A, Mohamed M, Onyeka S, Fisher M, Thapa J, Tabucanon EJ, Georgiev L, Wishart A, Kumari S, Erikson C, Bangura M, Paddy O, Madhukar R, Gomez EL, Rathod J, Naria M, Hajal B, Awadhalla M, Siegel D, Parmar H, Biran N, Vesole DH, Phull P, Weissman S. Interaction between age and gender on survival outcomes in extramedullary multiple myeloma over the past two decades. World J Clin Oncol 2023; 14(4): 179-189
  • URL: https://www.wjgnet.com/2218-4333/full/v14/i4/179.htm
  • DOI: https://dx.doi.org/10.5306/wjco.v14.i4.179